Showing results (1071-1080 of 3,524) with videos related to
Sort By:
Pageof 353
Bioelectricity|September 3, 2021
Electroconductive Hydrogels for Tissue Engineering: Current Status and Future PerspectivesZachary J Rogers, Michael P Zeevi, Ryan Koppes, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1982
Effect of cimetidine on the absorption and efficacy of orally administered furosemideH J Rogers, P Morrison, F R House, et al.Clinical Microbiology Reviews|August 11, 2021
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical DiseasesMadeleine J Rogers, Donald P McManus, Stephen Muhi, et al.Biochemistry|October 9, 2002
Aminophosphonate inhibitors of dialkylglycine decarboxylase: structural basis for slow binding inhibitionWenshe Liu, Claude J Rogers, Andrew J Fisher, et al.Molecular Biology and Evolution|July 1, 1992
DNA sequence polymorphism within hominoid species exceeds the number of phylogenetically informative characters for a HOX2 locusG Ruano, J Rogers, A C Ferguson-Smith, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1977
Phenytoin intoxication during concurrent diazepam therapyH J Rogers, R A Haslam, J Longstreth, et al.Cellular Immunology|September 1, 1984
Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressor (PITS). II. Resolution of multiple PITS beta factorsT J Rogers, J I DeHaven, R P Donnelly, et al.British Journal of Clinical Pharmacology|June 1, 1987
Influence of age, sex and body weight on the dapsone acetylation phenotypeP A Philip, S L Gayed, H J Rogers, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2014
Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1Filip Bednar, Changcheng Song, Giuseppe Bardi, et al.AIDS Care|August 11, 2012
Testing a service integration model: results from the HIV/AIDS initiative, ConnectHIVSusan J Rogers, Frank De Palomo, Stacey E Little, et al.Pageof 353